Latest News

Filters:

  • (Press "esc" to clear)

Science

Channels:

Keywords:

El Fortalecimiento de los Derechos Forestales Comunitarios es una Herramienta Fundamental para Luchar Contra el Cambio Climático, Indica un Nuevo e Importante Informe

El fortalecimiento de los derechos forestales comunitarios es una estrategia esencial para reducir los miles de millones de toneladas de emisiones de carbono, haciéndolo una forma efectiva para que los gobiernos cumplan los objetivos climáticos, salvaguarden los bosques y protejan las subsistencias de sus ciudadanos, según un importante reporte nuevo. El informe, llamado "Asegurando derechos, luchando contra el cambio climático: Cómo el fortalecimiento de los derechos forestales comunitarios mitiga el cambio climático", está siendo publicado conjuntamente por el Instituto de Recursos Mundiales (World Resources Institute - WRI) y la Iniciativa Derechos y Recursos (Rights and Resources Initiative - RRI). El documento proporciona el análisis más completo a la fecha vinculando el reconocimiento legal y la protección gubernamental de los derechos forestales comunitarios junto con las reducciones en la contaminación de carbono.

View | Comment

Science

Channels:

Keywords:

Strengthening Community Forest Rights is Critical Tool to Fight Climate Change, Says Major New Report

Strengthening community forest rights is an essential strategy to reduce billions of tonnes of carbon emissions, making it an effective way for governments to meet climate goals, safeguard forests and protect the livelihoods of their citizens, according to a major new report. The report, called “Securing Rights, Combating Climate Change: How Strengthening Community Forest Rights Mitigates Climate Change,” is being published jointly by World Resources Institute (WRI) and Rights and Resources Initiative (RRI). The paper provides the most comprehensive analysis to date linking legal recognition and government protection of community forest rights with reductions in carbon pollution.

View | Comment

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2014 5:00 AM EDT

Medicine

Channels:

Keywords:

UAB Enrolls Nation’s First Patient in Phase III Drug Trial for Preeclampsia

UAB has enrolled the first patient in the United States in a Phase III clinical trial for a drug to treat preeclampsia in pregnant women that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality.

View | Comment

Medicine

Channels:

Keywords:

Penn Study Reveals New Evidence Showing Medical Student Perceptions of Health Policy Education are Improving, but 40 Percent are Still Not Satisfied

Students graduating from U.S. medical schools in 2012 feel they’ve received a better education in health policy issues than graduates surveyed in 2008, according to a multi-center study led by the Perelman School of Medicine at the University of Pennsylvania, and published online this month in Academic Medicine. The study applied a new framework for teaching and evaluating perceptions of training in health policy, first proposed by the authors in a 2011 perspective published in the New England Journal of Medicine.

View | Comment

Medicine

Channels:

Keywords:

NIBIB to Host Second Edward C. Nagy New Investigator Symposium

The National Institute of Biomedical Imaging and Bioengineering will host its second Edward C. Nagy New Investigator Symposium on July 30, 2014 on the NIH campus. There will be ten exciting presentations from recent new investigators covering a wide breadth of NIBIB-funded research.

View | Comment

Science

Channels:

Keywords:

Is Your Data Safe? Why You Should Care More About Spam

Researchers are working to protect consumer data by using companies spam volume to evaluate its security vulnerability through the SpamRankings.net project.

View | Comment

Medicine

Channels:

Keywords:

Drug Approved to Treat Rare Disorder Associated with Anesthesia

henry-rosenberg.jpg

Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures. MH is an inherited and potentially fatal disorder triggered by certain anesthesia agents in genetically susceptible individuals. FDA had designated Ryanodex as an Orphan Drug in August 2013. Eagle has been informed by the FDA that it will learn over the next four to six weeks if it has been granted the seven year Orphan Drug market exclusivity.

View | Comment

Life

Arts and Humanities

Keywords:

From N.Y. Prisons to Slums of India & Thailand, Humanitarians Lauded for Opus Prize

SPOKANE, Wash. – After searching the world for great faith-based humanitarians, Gonzaga University announces three finalists for the 2014 Opus Prize (www.gonzaga.edu/opus-prize): Sister Tesa Fitzgerald of Hour Children, Queens, New York; Gollapalli Israel, of the Janodayam Social Education Centre in Chennai, India; and Rev. Joseph Maier, of the Mercy Centre Human Development Foundation in Bangkok.

View | Comment

Medicine

Channels:

Keywords:

Monitoring Pulse After Stroke May Prevent a Second Stroke

New research suggests that regularly monitoring your pulse after a stroke or the pulse of a loved one who has experienced a stroke may be a simple and effective first step in detecting irregular heartbeat, a major cause of having a second stroke. The study is published in the July 23, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

View | Comment